{
 "PrintNo":"A5032","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-02-10T15:20:17.049883Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2021-02-10","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO INSURANCE","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":468,"Name":"Philip Ramos","Short":"RAMOS"}],"Title":"Relates to coverage for single source drugs",
 "Summary":"Provides that every insurance policy which provides coverage for prescription drugs shall insure that there is continuous coverage of a single source drug that is part of a prescribed therapy until such prescribed therapy is no longer medically necessary for the enrollee of such policy; defines \"single source drug\".",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to coverage for single source drugs",
 "SameAsPrintNo":"S5901-2021",
 "PreviousVersions":["A4075-2007","A4131-2009","A4724-2011","A6130-2013","A4477-2015","A5273-2017","A4899-2019"]
}